Taiwan's health ministry launched the National Medical Informatics Certification Laboratory on August 18, 2026. Its three planned tracks cover software, FHIR Box hardware and solution providers, but interoperability tests do not establish clinical safety for medical AI.
A 2025 systematic review found that all six included studies, covering 689 children, reported gains in at least one developmental domain. No randomized trials were included, and WHO-UNICEF guidance says a concerning screen must lead to assessment and tracked follow-up rather than serve as a diagnosis.
A systematic review published in January 2026 found that generative AI increased the volume, speed and perceived credibility of health misinformation in the available studies. Clinicians can use the same tools to draft public information, but the evidence and professional guidance leave accuracy, privacy and disclosure with the person who publishes it.
Taiwan's national health insurer is targeting older adults who use three or more sleeping medicines for extended periods. The review combines prescription oversight with sleep assessments, while evidence links some sedative combinations to fall-related hospital admissions.
International guidance gives health organizations a practical set of controls to test before deploying generative AI. The work starts with data handling and audit design, then extends to source traceability, human authority and continuous monitoring.
Taiwan Health Nexus began operations on January 9, 2026, with plans to connect health records held by separate institutions for AI and research. Its public claims address interoperability, but evidence on consent, oversight and commercial reuse remains limited.
Taiwan launched TwHealth Nexus on January 9, 2026, with plans to connect health records held by hospitals and other care providers. The project goes beyond Taiwan's patient-facing My Health Bank service by proposing secondary data use for research and AI, raising separate questions about consent, withdrawal and oversight.
